Atlas Trials

Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Prospective Study

Clinical trial NCT06009042 · UNKNOWN

Trial details

NCT number
NCT06009042
Sponsor
Tongji Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HFRS (Hemorrhagic Fever With Renal Syndrome)
Start date
2022-07-01
Primary completion
2024-06-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.